Sunshine Biopharma Says After Conclusion Of Internal Review Of Lab Results, Gave Notice To Jewish General Hospital Of Termination Of Research Agreement; Now Paused IND-Enabling Studies Of Adva-27a Effective On December 2, 2023

Never miss a trade again with the fastest news alerts in the world!

This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday.

Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!